Skip to main content Accessibility help
×
    • You have access
    • Open access
Publisher:
Cambridge University Press
Online publication date:
December 2024
Print publication year:
2024
Online ISBN:
9781009282406
Creative Commons:
Creative Common License - CC Creative Common License - BY Creative Common License - NC Creative Common License - ND
This content is Open Access and distributed under the terms of the Creative Commons Attribution licence CC-BY-NC-ND 4.0 https://creativecommons.org/creativelicenses

Book description

This volume assesses the role of intellectual property in pandemic times through lessons learned from COVID-19. Authored by an international roster of experts, chapters diagnose causes for the inequitable distribution of lifesaving COVID-19 vaccines and offer concrete suggestions for reform. From delinking vaccine development from monopoly rights in technology, to enhanced legal requirements under national and international law for sharing publicly funded technologies, to requiring funding from rich nations to former colonies to build local vaccine manufacturing capacity in low and middle-income countries (including those in Africa), this work highlights timely IP reforms that prepare us for the next pandemic. This title is also available as Open Access on Cambridge Core.

Refine List

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
×

Contents

Full book PDF
  • Intellectual Property, COVID-19, and the Next Pandemic
    pp i-ii
  • Copyright page
    pp iv-iv
  • Contents
    pp v-vi
  • Contributors
    pp vii-viii
  • Introduction
    pp 1-36
  • Intellectual Property and “The Lost Year” of COVID-19 Deaths
  • Part I - Reconsidering Key Theoretical and Policy Issues
    pp 37-132
  • 2 - Global Medical War Chest
    pp 63-85
  • 3 - COVID-19 and Boundary-Crossing Collaboration
    pp 86-105
  • 4 - Legal Paradigms and the Politics of Global COVID-19 Vaccine Access
    pp 106-132
  • Part II - Boosting Low-Income Countries’ Capacities for Protecting Public Health
    pp 133-240
  • 6 - Patent Philanthropy
    pp 168-194
  • 7 - Beyond Traditional IP
    pp 195-216
  • Addressing Regulatory Barriers
  • Part III - Alternative Means of Fighting Pandemics
    pp 241-340
  • 9 - Planning for Pandemic and Epidemic-Related Scarcity of Medicines
    pp 243-254
  • 10 - Improving Global Governance of Pandemic Response
    pp 255-286
  • Lessons from COVID-19
  • 11 - Compelling Trade Secret Sharing
    pp 287-314
  • 12 - Voluntary Intellectual Property Pledges and COVID-19
    pp 315-340
  • Part IV - Toward Dynamic Protection of Public Health in China, Africa, and Latin America
    pp 341-342
  • 13 - China, the TRIPS Waiver, and the Global Pandemic Response
    pp 343-363
  • 14 - COVID-19 Exclusion, Policy Contagion, and Colonial Hangover in Africa
    pp 364-381
  • 15 - Technology Transfer for Production of COVID-19 Vaccines in Latin America
    pp 382-412

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Book summary page views

Total views: 0 *
Loading metrics...

* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

Usage data cannot currently be displayed.